188 related articles for article (PubMed ID: 38376151)
1. Investigating inhibitors of 1-deoxy-d-xylulose 5-phosphate synthase in a mouse model of UTI.
Chen EC; Shapiro RL; Pal A; Bartee D; DeLong K; Carter DM; Serrano-Diaz E; Rais R; Ensign LM; Freel Meyers CL
Microbiol Spectr; 2024 Apr; 12(4):e0389623. PubMed ID: 38376151
[TBL] [Abstract][Full Text] [Related]
2. DXP Synthase Function in a Bacterial Metabolic Adaptation and Implications for Antibacterial Strategies.
Chen EC; Freel Meyers CL
Antibiotics (Basel); 2023 Apr; 12(4):. PubMed ID: 37107054
[TBL] [Abstract][Full Text] [Related]
3. Enamide Prodrugs of Acetyl Phosphonate Deoxy-d-xylulose-5-phosphate Synthase Inhibitors as Potent Antibacterial Agents.
Bartee D; Sanders S; Phillips PD; Harrison MJ; Koppisch AT; Freel Meyers CL
ACS Infect Dis; 2019 Mar; 5(3):406-417. PubMed ID: 30614674
[TBL] [Abstract][Full Text] [Related]
4. Potent Inhibition of
Coco LB; Toci EM; Chen PY; Drennan CL; Freel Meyers CL
ACS Infect Dis; 2024 Apr; 10(4):1312-1326. PubMed ID: 38513073
[TBL] [Abstract][Full Text] [Related]
5. Photochemical inactivation as an alternative method to produce a whole-cell vaccine for uropathogenic
Westcott MM; Morse AE; Troy G; Blevins M; Wierzba T; Sanders JW
Microbiol Spectr; 2024 Mar; 12(3):e0366123. PubMed ID: 38315025
[TBL] [Abstract][Full Text] [Related]
6. Not Every Hit-Identification Technique Works on 1-Deoxy-d-Xylulose 5-Phosphate Synthase (DXPS): Making the Most of a Virtual Screening Campaign.
Johannsen S; Gierse RM; Olshanova A; Smerznak E; Laggner C; Eschweiler L; Adeli Z; Hamid R; Alhayek A; Reiling N; Haupenthal J; Hirsch AKH
ChemMedChem; 2023 Jun; 18(11):e202200590. PubMed ID: 36896721
[TBL] [Abstract][Full Text] [Related]
7. Conformational dynamics of 1-deoxy-d-xylulose 5-phosphate synthase on ligand binding revealed by H/D exchange MS.
Zhou J; Yang L; DeColli A; Freel Meyers C; Nemeria NS; Jordan F
Proc Natl Acad Sci U S A; 2017 Aug; 114(35):9355-9360. PubMed ID: 28808005
[TBL] [Abstract][Full Text] [Related]
8. First crystal structures of 1-deoxy-D-xylulose 5-phosphate synthase (DXPS) from Mycobacterium tuberculosis indicate a distinct mechanism of intermediate stabilization.
Gierse RM; Oerlemans R; Reddem ER; Gawriljuk VO; Alhayek A; Baitinger D; Jakobi H; Laber B; Lange G; Hirsch AKH; Groves MR
Sci Rep; 2022 May; 12(1):7221. PubMed ID: 35508530
[TBL] [Abstract][Full Text] [Related]
9. Host-Derived Nitric Oxide and Its Antibacterial Effects in the Urinary Tract.
Svensson L; Poljakovic M; Demirel I; Sahlberg C; Persson K
Adv Microb Physiol; 2018; 73():1-62. PubMed ID: 30262107
[TBL] [Abstract][Full Text] [Related]
10. CpxA Phosphatase Inhibitor Activates CpxRA and Is a Potential Treatment for Uropathogenic Escherichia coli in a Murine Model of Infection.
Fortney KR; Smith SN; van Rensburg JJ; Brothwell JA; Gardner JJ; Katz BP; Ahsan N; Duerfeldt AS; Mobley HLT; Spinola SM
Microbiol Spectr; 2022 Apr; 10(2):e0243021. PubMed ID: 35297652
[TBL] [Abstract][Full Text] [Related]
11. Secretory leukocyte protease inhibitor protects against severe urinary tract infection in mice.
Rosen AL; Lint MA; Voelker DH; Gilbert NM; Tomera CP; Santiago-Borges J; Wallace MA; Hannan TJ; Burnham C-AD; Hultgren SJ; Kau AL
mBio; 2024 Feb; 15(2):e0255423. PubMed ID: 38270443
[TBL] [Abstract][Full Text] [Related]
12. Antibacterial Target DXP Synthase Catalyzes the Cleavage of d-Xylulose 5-Phosphate: a Study of Ketose Phosphate Binding and Ketol Transfer Reaction.
Johnston ML; Bonett EM; DeColli AA; Freel Meyers CL
Biochemistry; 2022 Sep; 61(17):1810-1823. PubMed ID: 35998648
[TBL] [Abstract][Full Text] [Related]
13. X-ray crystallography-based structural elucidation of enzyme-bound intermediates along the 1-deoxy-d-xylulose 5-phosphate synthase reaction coordinate.
Chen PY; DeColli AA; Freel Meyers CL; Drennan CL
J Biol Chem; 2019 Aug; 294(33):12405-12414. PubMed ID: 31239351
[TBL] [Abstract][Full Text] [Related]
14. Previous Antibiotic Exposure Reshapes the Population Structure of Infecting Uropathogenic Escherichia coli Strains by Selecting for Antibiotic Resistance over Urovirulence.
Ballash GA; Diaz-Campos D; van Balen JC; Mollenkopf DF; Wittum TE
Microbiol Spectr; 2023 Aug; 11(4):e0524222. PubMed ID: 37338386
[TBL] [Abstract][Full Text] [Related]
15. Phage Resistance Accompanies Reduced Fitness of Uropathogenic Escherichia coli in the Urinary Environment.
Zulk JJ; Clark JR; Ottinger S; Ballard MB; Mejia ME; Mercado-Evans V; Heckmann ER; Sanchez BC; Trautner BW; Maresso AW; Patras KA
mSphere; 2022 Aug; 7(4):e0034522. PubMed ID: 35920561
[TBL] [Abstract][Full Text] [Related]
16. Targeting the Unique Mechanism of Bacterial 1-Deoxy-d-xylulose-5-phosphate Synthase.
Bartee D; Freel Meyers CL
Biochemistry; 2018 Jul; 57(29):4349-4356. PubMed ID: 29944345
[TBL] [Abstract][Full Text] [Related]
17. VesiX cetylpyridinium chloride is rapidly bactericidal and reduces uropathogenic
Sawant NV; Chang SS; Pandit KA; Khekare P; Warner WR; Zimmern PE; De Nisco NJ
Microbiol Spectr; 2024 Mar; 12(3):e0271223. PubMed ID: 38240572
[TBL] [Abstract][Full Text] [Related]
18. Toward Understanding the Chemistry and Biology of 1-Deoxy-d-xylulose 5-Phosphate (DXP) Synthase: A Unique Antimicrobial Target at the Heart of Bacterial Metabolism.
Bartee D; Freel Meyers CL
Acc Chem Res; 2018 Oct; 51(10):2546-2555. PubMed ID: 30203647
[TBL] [Abstract][Full Text] [Related]
19. Oral supplementation of trans-cinnamaldehyde reduces uropathogenic Escherichia coli colonization in a mouse model.
Narayanan A; Muyyarikkandy MS; Mooyottu S; Venkitanarayanan K; Amalaradjou MA
Lett Appl Microbiol; 2017 Mar; 64(3):192-197. PubMed ID: 28063174
[TBL] [Abstract][Full Text] [Related]
20. [Investigation of Virulence Factors, Phylogenetic Group Features, and the Presence of ST131 Clone in Escherichia coli Isolates, a Urinary Tract Infection Agent in Children].
Kılıç SG; Öcal D; Tekeli A; Dolapçı İ
Mikrobiyol Bul; 2023 Oct; 57(4):535-552. PubMed ID: 37885384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
